相似文献
1
Triple therapy vs. dual bronchodilator therapy for chronic obstructive pulmonary disease: Is it worth the cost?
Respir Investig. 2015 Jul;53(4):173-5. doi: 10.1016/j.resinv.2015.01.006. Epub 2015 Feb 28.
2
The cost-saving switch from inhaled corticosteroid-containing treatments to dual bronchodilation: a two-country projection of epidemiological and economic burden in chronic obstructive pulmonary disease.
Ther Adv Respir Dis. 2020 Jan-Dec;14:1753466620926802. doi: 10.1177/1753466620926802.
3
Triple therapy for chronic obstructive pulmonary disease: trials catching up with clinical practice?
Am J Respir Crit Care Med. 2009 Oct 15;180(8):689-90. doi: 10.1164/rccm.200908-1205ED.
4
A pragmatic approach to simplify inhaler therapy for COPD.
Lancet Respir Med. 2017 Sep;5(9):679-681. doi: 10.1016/S2213-2600(17)30264-3. Epub 2017 Jul 7.
5
COUNTERPOINT: Should an Attempt Be Made to Withdraw Inhaled Corticosteroids in All Patients With Stable GOLD 3 (30% ≤ FEV < 50% Predicted) COPD? No.
Chest. 2018 Apr;153(4):782-784. doi: 10.1016/j.chest.2018.01.030. Epub 2018 Feb 2.
6
Triple inhalers for obstructive airways disease: will they be useful?
Expert Rev Respir Med. 2011 Jun;5(3):297-300. doi: 10.1586/ers.11.26.
7
POINT: Should an Attempt Be Made to Withdraw Inhaled Corticosteroids in All Patients With Stable GOLD 3 (30% ≤ FEV < 50% Predicted) COPD? Yes.
Chest. 2018 Apr;153(4):778-782. doi: 10.1016/j.chest.2018.01.029. Epub 2018 Feb 21.
8
Switching treatments in COPD: implications for costs and treatment adherence.
Int J Chron Obstruct Pulmon Dis. 2015 Dec 3;10:2601-8. doi: 10.2147/COPD.S79635. eCollection 2015.
9
[Drugs for chronic obstructive pulmonary disorder].
Tidsskr Nor Laegeforen. 2019 Oct 7;139(14). doi: 10.4045/tidsskr.19.0181. Print 2019 Oct 8.
10
[Combined inhaled corticosteroid and long-acting beta-2-agonist in one inhaler in the treatment of chronic obstructive pulmonary disease].
Ugeskr Laeger. 2005 Jun 6;167(23):2504-6.
Zotero 插件